The Enterprise Value as of October 2024 (TTM) for Ikena Oncology, Inc. (IKNA) is 47.35M

According to Ikena Oncology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 47.35M. This represents a change of 43.75% compared to the average of 32.94M of the last 4 quarters.

Ikena Oncology, Inc. (IKNA) Historical Enterprise Value (quarterly & annually)

How has IKNA Enterprise Value performed in the past?

The mean historical Enterprise Value of Ikena Oncology, Inc. over the last ten years is 593.60M. The current 47.35M Enterprise Value has changed 697.59% with respect to the historical average. Over the past ten years (40 quarters), IKNA's Enterprise Value was at its highest in in the March 2020 quarter at 529.68M. The Enterprise Value was at its lowest in in the March 2021 quarter at -164603042.00.

Ikena Oncology, Inc. (IKNA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ikena Oncology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ikena Oncology, Inc. (IKNA) Average Enterprise Value

How has IKNA Enterprise Value performed in the past?

The current Enterprise Value of Ikena Oncology, Inc. (IKNA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Ikena Oncology, Inc. (IKNA) Enterprise Value vs. Peers

How is IKNA’s Enterprise Value compared to its peers?

Ikena Oncology, Inc.’s Enterprise Value is less than Edgewise Therapeutics, Inc. (3.29B), less than Design Therapeutics, Inc. (297.86M), greater than Xilio Therapeutics, Inc. (-31544533.00), less than Eliem Therapeutics, Inc. (119.64M), less than Monte Rosa Therapeutics, Inc. (272.45M), greater than Werewolf Therapeutics, Inc. (-9037490.00), less than Stoke Therapeutics, Inc. (510.91M), greater than Anebulo Pharmaceuticals, Inc. (44.36M), less than Celcuity Inc. (638.17M), greater than MediciNova, Inc. (44.68M), less than Rezolute, Inc. (196.93M), greater than Aerovate Therapeutics, Inc. (36.59M), less than Decibel Therapeutics, Inc. (96.42M), less than Foghorn Therapeutics Inc. (330.21M), greater than Shattuck Labs, Inc. (8.99M), less than Kymera Therapeutics, Inc. (2.97B), less than Nurix Therapeutics, Inc. (1.68B),

Build a custom stock screener for Ikena Oncology, Inc. (IKNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ikena Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ikena Oncology, Inc. (IKNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ikena Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.